Apollo Atomics
Apollo Atomics Raises $31M Seed for Factory-Built Nuclear Reactors
Apollo Atomics announced $31M in Seed financing on August 20, 2026. Apollo Atomics raised $31 million in seed financing led by FCVC to commercialize a factory-manufacturable nuclear platform built on compact pressurized water reactors.
Round details
The financing includes backing from FCVC, Y Combinator, Telesoft Partners, Alumni Ventures, Robinhood Ventures, Nucleation Capital, Pelion VC, Duke Capital Partners. The company did not publish a valuation with the announcement.
- Round: Seed
- Capital announced: $31M
How the company plans to use the capital
Apollo Atomics said the capital will expand demonstration and long-duration reliability testing, build manufacturing capacity, and advance regulatory work with the U.S. Nuclear Regulatory Commission. The financing will also support construction of its 1 MW A-1 demonstrator and expansion of its engineering and operations capabilities.
Why this matters for GTM teams
The round points to investor interest in compact, factory-built nuclear reactors, which the company said are designed to serve data centers, industrial facilities, utilities and other large energy users.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Apollo Atomics Seed announcement.
Company Info
Investors (8)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


